CELG.RT
Bristol-Myers Squibb Rights
CELG.RT
CELG.RT
28 hedge funds and large institutions have $248K invested in Bristol-Myers Squibb Rights in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$36K | |
| 2 | +$8K | |
| 3 | +$8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.72K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.43K |
Top Sellers
| 1 | -$56K | |
| 2 | -$11K | |
| 3 | -$8.78K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6K |
| 5 |
HR
Howe & Rusling
Rochester,
New York
|
-$1K |